These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 7475461

  • 1. [The efficacy of sulbactam-ampicillin in a urinary infection due to Acinetobacter calcoaceticus var. anitratus].
    Telenti Asensio M, Moreno Torrico A, Ruiz Palomar J, Bernaldo de Quirós JF.
    Med Clin (Barc); 1995 Oct 07; 105(11):438-9. PubMed ID: 7475461
    [No Abstract] [Full Text] [Related]

  • 2. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus.
    Urban C, Go E, Mariano N, Berger BJ, Avraham I, Rubin D, Rahal JJ.
    J Infect Dis; 1993 Feb 07; 167(2):448-51. PubMed ID: 8421178
    [Abstract] [Full Text] [Related]

  • 3. Restricting the use of ampicillin-sulbactam.
    Zavascki AP, Sandri AM.
    J Hosp Infect; 2004 Feb 07; 56(2):165-6. PubMed ID: 15019231
    [No Abstract] [Full Text] [Related]

  • 4. In-vitro activity of ampicillin/sulbactam against multiresistant Acinetobacter calcoaceticus var. anitratus clinical isolates.
    Douboyas J, Tzouvelekis LS, Tsakris A.
    J Antimicrob Chemother; 1994 Aug 07; 34(2):298-300. PubMed ID: 7814296
    [No Abstract] [Full Text] [Related]

  • 5. Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
    Oliveira MS, Prado GV, Costa SF, Grinbaum RS, Levin AS.
    J Antimicrob Chemother; 2008 Jun 07; 61(6):1369-75. PubMed ID: 18367459
    [Abstract] [Full Text] [Related]

  • 6. Concerning the sensitivity of Acinetobacter calcoaceticus.
    Jedlicková Z, Tesaríková E, Výmola F.
    J Hyg Epidemiol Microbiol Immunol; 1990 Jun 07; 34(1):73-6. PubMed ID: 2351822
    [Abstract] [Full Text] [Related]

  • 7. Clinical evaluation of sulbactam + ampicillin in the treatment of pediatric urinary tract infections.
    Solbiati M, Danzi MC, D'Orazio C, Bassetti D.
    Chemioterapia; 1988 Dec 07; 7(6):393-5. PubMed ID: 3219751
    [Abstract] [Full Text] [Related]

  • 8. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
    Sayin Kutlu S, Saçar S, Süzer T, Cevahir N, Okke D, Dirgen Caylak S, Turgut H.
    Mikrobiyol Bul; 2008 Apr 07; 42(2):353-8. PubMed ID: 18697435
    [Abstract] [Full Text] [Related]

  • 9. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii.
    Urban C, Segal-Maurer S, Rahal JJ.
    Clin Infect Dis; 2003 May 15; 36(10):1268-74. PubMed ID: 12746772
    [Abstract] [Full Text] [Related]

  • 10. Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians.
    Jain R, Danziger LH.
    Ann Pharmacother; 2004 Sep 15; 38(9):1449-59. PubMed ID: 15280512
    [Abstract] [Full Text] [Related]

  • 11. [Intrahospital septicemia due to Acinetobacter calcoaceticus var. anitratus in a neonatal intensive care unit].
    Vivanco G, Figueroa A.
    Rev Chil Pediatr; 1991 Sep 15; 62(5):297-301. PubMed ID: 1844938
    [Abstract] [Full Text] [Related]

  • 12. Nosocomial meningitis due to Acinetobacter calcoaceticus in 10 children after ventriculoperitoneal shunt insertion.
    Filka J, Huttova M, Schwartzová D, Kurak M, Krcméryová T, Tuharský J, Kralinský K, Sagát T, Krcmérý V.
    J Hosp Infect; 2000 Jan 15; 44(1):76-7. PubMed ID: 10633059
    [No Abstract] [Full Text] [Related]

  • 13. Use of inhaled ampicillin-sulbactam against multiresistant Acinetobacter baumannii in bronchial secretions of intensive care unit patients.
    Horianopoulou M, Kanellopoulou M, Paraskevopoulos I, Kyriakidis A, Legakis NJ, Lambropoulos S.
    Clin Microbiol Infect; 2004 Jan 15; 10(1):85-6. PubMed ID: 14706094
    [No Abstract] [Full Text] [Related]

  • 14. [Use of sulbactam/ampicillin in the treatment of infections at various sites].
    Migliorato D, Consolo A, Migliorato A, Leone E, Canale MP.
    G Ital Chemioter; 1987 Jan 15; 34(1-3):47-55. PubMed ID: 3504414
    [No Abstract] [Full Text] [Related]

  • 15. Infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus.
    Wood CA, Reboli AC.
    J Infect Dis; 1993 Dec 15; 168(6):1602-3. PubMed ID: 8245560
    [No Abstract] [Full Text] [Related]

  • 16. Intravenous sulbactam/ampicillin in the treatment of pediatric infections.
    Lee CY, Lin TY, Chu ML, Lee MJ, Hsu CY, Huang LM, Chen CM.
    Diagn Microbiol Infect Dis; 1989 Dec 15; 12(4 Suppl):179S-183S. PubMed ID: 2686918
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Evolution of antimicrobial susceptibility of Acinetobacter baumannii clinical isolates].
    López-Hernández S, Alarcón T, López-Brea M.
    Rev Esp Quimioter; 2000 Dec 15; 13(4):394-400. PubMed ID: 11498706
    [Abstract] [Full Text] [Related]

  • 20. Optimizing therapy for Acinetobacter baumannii.
    Peleg AY.
    Semin Respir Crit Care Med; 2007 Dec 15; 28(6):662-71. PubMed ID: 18095230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.